Adalyon Names Ulrik Zeuthen as Chief Executive Officer to Lead Next Phase Espoo, Finland, Nov. 25, 2025 — Adalyon, a pioneer in AI-powered speech biomarker technology for clinical drug development, today announced the appointment of Ulrik Zeuthen as Chief Executive Officer. The move signals a strategic push to accelerate the company’s growth trajectory and advance…